| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00021 | 1 |